Vico Therapeutics strengthens its Board along with raising $31m Series A financing co-led by Life Science Partners and Kurma Partners
– NETHERLANDS, Leiden – Vico Therapeutics, a Leiden, the Netherlands, based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, today announced that it has raised $31 million (€27 million) in a Series A financing round led by Life Science Partners, co-led by Kurma Partners, and supported by Pontifax, Droia Genetic Disease, Polaris Partners and Pureos Bioventures and Idinvest Partners.…